Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Perfluorooctane sulfonic acid (PFOS) is a synthetic, fully fluorinated organic acid belonging to the class of per- and polyfluoroalkyl substances (PFAS). It is not a therapeutic target but rather a persistent environmental pollutant and toxicant known for its extreme chemical stability and bioaccumulative properties [3, 15]. PFOS exerts its biological effects by interacting with various nuclear receptors, most notably acting as an agonist for the peroxisome proliferator-activated receptor alpha (PPAR-alpha) and the orphan nuclear receptor 4A1 (NR4A1) [1, 14]. These interactions lead to significant disruptions in lipid metabolism, endocrine function, and immune responses [4, 9]. Clinically, elevated PFOS levels are associated with hepatotoxicity, hypercholesterolemia, thyroid dysfunction, and impaired vaccine response [8, 11]. While not a drug target, its elimination from the body can be accelerated by bile acid sequestrants like cholestyramine, which interrupt its enterohepatic circulation [8, 12]. Its persistence in the environment and human body has led to its classification as a 'forever chemical' and its inclusion in the Stockholm Convention on Persistent Organic Pollutants [15]. Research continues to investigate its role as a potential carcinogen, with the IARC classifying it as possibly carcinogenic to humans [18].
Bile acid sequestrants like cholestyramine bind to PFOS in the gastrointestinal tract, preventing its reabsorption and interrupting its enterohepatic circulation, thereby increasing its fecal excretion [8, 12].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Perfluorooctane sulfonic acid (PFOS).